Home › Funds › PNC Financial Services › FDMT
PNC Financial Services position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)1.48K sh
Reported value held$19.71K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 32 | $648 | New |
| Q1 2024 | 28 | $892 | Reduce |
| Q2 2024 | 4.36K | $91.52K | Add |
| Q3 2024 | 5.49K | $59.39K | Add |
| Q4 2024 | 9.12K | $50.82K | Add |
| Q1 2025 | 7.90K | $25.53K | Reduce |
| Q2 2025 | 9.16K | $33.98K | Add |
| Q3 2025 | 7.31K | $63.49K | Reduce |
| Q4 2025 | 7.17K | $53.81K | Reduce |
| Q1 2026 | 1.46K | $13.61K | Reduce |
| Q2 2026 | 1.48K | $19.71K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Citadel Advisors 901.20K sh · $11.99M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026